Support independent, student-run journalism.

Your support helps give staff members from all backgrounds the opportunity to conduct meaningful reporting on important issues at Stanford. All contributions are tax-deductible.

Laboratory for Cell and Gene Medicine opens in Palo Alto

Stanford’s Laboratory for Cell and Gene Medicine (LCGM), the university’s first manufacturing facility specifically designed to adhere to the Food and Drug Administration’s (FDA’s) current good manufacturing practices (CGMPs), opened this month in Palo Alto.

This recent partnership between the Stanford School of Medicine, Stanford Health Care and Stanford Children’s Health is dedicated towards developing biological products for phase-1 and phase-2 clinical trials.

Stanford researchers use stem cells to create pure populations of human cell types

Researchers at the Stanford University School of Medicine have discovered the combinations of biological and chemical signals needed to rapidly generate human cell types from human embryonic stem cells, according to Stanford Medicine News. Pure populations of up to 12 cell types can now be created in five to nine days, as opposed to the weeks or months previously required.

Researchers to revisit drug trials for major viruses

Stanford scientists have relaunched research on a previously shelved category of drugs, known as broad-spectrum antiviral drugs, in the hope that it will reveal information about new strategies to fight both difficult-to-combat viruses such as dengue and ebola, along with cancer.

This research, published in Nature Chemical Biology, was headed by the two senior authors of the paper, assistant professor of genetics Michael Bassik and professor of chemistry Chaitan Khosla.

Stanford Medicine appoints new chair of pathology

Thomas Montine, current chair of pathology at the University of Washington, was recently appointed as the new chair of the Stanford University School of Medicine’s Department of Pathology. According to Stanford Medicine’s News Center, Montine’s term starts on May 1.

According to Paul Khavar, Chair of Dermatology and a co-leader of the search committee for the new chair of pathology, Montine’s leadership within the realm of neuropathology, especially in genomics, complements Stanford Medicine’s goal of providing better patient care.